# Jazz Pharmaceuticals plc (JAZZ) FY2026 Q2 Balance Sheet

- Company: Jazz Pharmaceuticals plc (JAZZ)
- Period: As of 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-03, accession number 0001232524-26-000045
- Page: https://plicit.ai/financials/jazz/fy2026-q2-balance-sheet
- Chart image: https://plicit.ai/charts/jazz-fy2026-q2-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 11,080,900,000 US dollars
- **Current assets**: 3,968,200,000 US dollars
- **Non-current assets**: 7,112,700,000 US dollars
- **Liabilities (calculated)**: 6,279,200,000 US dollars
- **Current liabilities**: 2,230,800,000 US dollars
- **Non-current liabilities**: 4,048,400,000 US dollars
- **Equity**: 4,801,700,000 US dollars
- **Cash and cash equivalents**: 1,619,800,000 US dollars
- **Accounts receivable, net of allowances**: 880,900,000 US dollars
- **Investments**: 580,000,000 US dollars
- **Inventories**: 443,000,000 US dollars
- **Other current assets**: 244,500,000 US dollars
- **Prepaid expenses**: 200,000,000 US dollars
- **Intangible assets, net**: 4,029,500,000 US dollars
- **Goodwill**: 1,799,800,000 US dollars
- **Deferred tax assets, net**: 926,400,000 US dollars
- **Property, plant and equipment, net**: 212,000,000 US dollars
- **Other non-current assets**: 86,300,000 US dollars
- **Operating lease assets**: 52,100,000 US dollars
- **Deferred financing costs**: 6,600,000 US dollars
- **Accrued liabilities**: 1,030,000,000 US dollars
- **Current portion of long-term debt**: 1,016,400,000 US dollars
- **Accounts payable**: 128,500,000 US dollars
- **Income taxes payable**: 55,900,000 US dollars
- **Long-term debt, less current portion**: 3,335,000,000 US dollars
- **Deferred tax liabilities, net**: 528,900,000 US dollars
- **Other non-current liabilities**: 140,900,000 US dollars
- **Operating lease liabilities, less current portion**: 43,600,000 US dollars
- **Additional paid-in capital**: 4,331,600,000 US dollars
- **Retained earnings**: 1,132,000,000 US dollars
- **Capital redemption reserve**: 500,000 US dollars
- **Non-voting euro deferred shares**: 100,000 US dollars
- **Ordinary shares**: 0 US dollars
- **Accumulated other comprehensive loss**: negative 662,500,000 US dollars
- **Gross equity (calculated)**: 5,464,200,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.